AstraZeneca

The Pharmacy and Poisons Board last week cleared the AstraZeneca Covid-19 vaccine for use in Kenya, paving the way for its rollout.

| AFP

Covid-19 vaccine importers to shoulder burden of risks

What you need to know:

  • Government requires all suppliers to sign an indemnity agreement.
  • They’ll be liable to compensate aggrieved parties should they successfully sue.

Manufacturers planning to import Covid-19 vaccines into Kenya must be ready to take responsibility for any adverse effects the drugs might have on users.

Welcome!

You're all set to enjoy unlimited Prime content.